 Captrust Financial Advisors acquired a new stake in Meridian Bioscience, Inc. NASDAQ:VIVO in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 1,770 shares of the companys stock, valued at approximately 40,000. Several other institutional investors and hedge funds have also recently added to ... 